WeylChem InnoTec, based in Germany, is the innovative partner to the pharmaceutical and electronics industry. With competencies in Analytics, Research and Custom Synthesis, we are specialized in contract development and manufacturing of highly sophisticated materials using multi-step synthetic routes. As a highlight, our special technologies include cryogenic reactions read moreconditions down to -100°C, handling organometallic compounds and high-pressure reactions up to 3000 psi e.g. Hydrogenations and Hydroformylations. We combine these challenging with the whole range of modern organic chemistry using state-of-the-art, multipurpose facilities with 80 different stirred reaction vessels ranging from 40 to 5000 liters.

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi read moreAppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its openaccess platform is enabling more than 5,800 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com